For simultaneous identification of mutations and CNVs in 26 selected genes associated with hereditary breast, ovarian and other cancers by MPS
The BRCA Hereditary Cancer MASTR Plus is a molecular assay for the identification of all mutations and CNVs in the 26 selected genes, as listed in Figure 1 in the Specifications section, associated with hereditary breast, ovarian and other related cancers.
Multiplicom’s BRCA Hereditary Cancer MASTR Plus assay is provided as a ready-to-use kit that offers robust performance with minimum hands-on time. All reagents necessary to enable multiplex amplification of 561 amplicons (232-430 bp) in 5 PCR reactions are included, for complete coverage of all coding sequences and selected intronic regions.
The assay is compatible with most current Massively Parallel Sequencing (MPS) systems, providing the flexibility to choose your preferred method.